Literature DB >> 22377708

Epidemiology and geographical variation of myasthenia gravis in the province of Pavia, Italy.

Cristina Montomoli1, Antonietta Citterio, Giovanni Piccolo, Rita Cioccale, Virginia V Ferretti, Cesare Fratti, Roberto Bergamaschi, Vittorio E Cosi.   

Abstract

BACKGROUND AND AIMS: Previous studies have reported a prevalence estimate of myasthenia gravis (MG) from 7.7 to 11.1 per 100,000 inhabitants in Europe. Moreover, the study of the geographical distribution of MG should be useful to generate specific hypotheses. The aims are to estimate MG prevalence and to investigate its geographical variation in a delimited area in Northern Italy.
METHODS: The primary source of data was the MG database of the Neurological Institute of Pavia and all other sources of case collection in and outside the province. We adopted a Bayesian approach to analyze MG geographical variation within the finest geographical grid.
RESULTS: We identified 119 live MG prevalent cases resident in the province of Pavia on December 31, 2008. The overall crude prevalence was 24 per 100,000 inhabitants. The Bayesian analysis identified a small cluster of higher MG prevalence in the northern area of the province.
CONCLUSIONS: The estimated MG prevalence sets the province of Pavia among the high-risk areas. The identification of high/low MG risk areas deserves further investigation of genetic and environmental factors possibly related to a major risk of the disease in that area.
Copyright © 2012 S. Karger AG, Basel.

Entities:  

Mesh:

Year:  2012        PMID: 22377708     DOI: 10.1159/000336002

Source DB:  PubMed          Journal:  Neuroepidemiology        ISSN: 0251-5350            Impact factor:   3.282


  5 in total

1.  Thymomatous myasthenia gravis: novel association with HLA DQB1*05:01 and strengthened evidence of high clinical and serological severity.

Authors:  Roberto Massa; Giulia Greco; Manuela Testi; Emanuele Rastelli; Chiara Terracciano; Erica Frezza; Matteo Garibaldi; Girolama A Marfia; Franco Locatelli; Nicola B Mercuri; Eugenio Pompeo; Giovanni Antonini; Marco Andreani
Journal:  J Neurol       Date:  2019-02-11       Impact factor: 4.849

Review 2.  The epidemiology of myasthenia gravis.

Authors:  Ana-Maria Bubuioc; Aigerim Kudebayeva; Saule Turuspekova; Vitalie Lisnic; Maurizio Angelo Leone
Journal:  J Med Life       Date:  2021 Jan-Mar

3.  Global prevalence of myasthenia gravis and the effectiveness of common drugs in its treatment: a systematic review and meta-analysis.

Authors:  Nader Salari; Behnaz Fatahi; Yalda Bartina; Mohsen Kazeminia; Reza Fatahian; Payam Mohammadi; Shamarina Shohaimi; Masoud Mohammadi
Journal:  J Transl Med       Date:  2021-12-20       Impact factor: 5.531

4.  Familial aggregation of myasthenia gravis in affected families: a population-based study.

Authors:  Fu-Chao Liu; Chang-Fu Kuo; Lai-Chu See; Hsin-I Tsai; Huang-Ping Yu
Journal:  Clin Epidemiol       Date:  2017-11-02       Impact factor: 4.790

5.  Epidemiology of Myasthenia Gravis in Sweden 2006-2016.

Authors:  Elisabet Westerberg; Anna Rostedt Punga
Journal:  Brain Behav       Date:  2020-09-01       Impact factor: 2.708

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.